" /> Cereblon E3 Ubiquitin Ligase Modulating Drug BMS-986449 - CISMeF





Preferred Label : Cereblon E3 Ubiquitin Ligase Modulating Drug BMS-986449;

NCIt synonyms : CelMoD BMS-986449; Cereblon E3 Ubiquitin Ligase Modulating Agent BMS-986449; Cereblon Modulator BMS-986449; Cereblon Modulating Drug BMS-986449; IKZF2/IKZF4 Degrader BMS-986449;

NCIt definition : A modulator of the E3 ubiquitin ligase complex containing cereblon (CRL4-CRBN E3 ubiquitin ligase), with potential immunomodulating and antineoplastic activities. Upon administration, BMS-986449 specifically targets and binds to cereblon (CRBN), thereby affecting the ubiquitin E3 ligase activity, and targeting certain substrate proteins for ubiquitination. This induces proteasome-mediated degradation of certain transcription factors, some of which are transcriptional repressors in regulatory T-cells (Tregs), such as Ikaros family zinc finger protein 2 (IKZF2; zinc finger protein Helios), and IKZF4 (zinc finger protein Eos). This reprograms Tregs and leads to the modulation of the immune system, including activation of T-lymphocytes, and results in a T-cell-mediated anti-tumor immune response.;

Molecule name : BMS 986449; BMS-986449;

Détails


Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.